184 related articles for article (PubMed ID: 25025048)
1. Quercetin significantly inhibits the metabolism of caffeine, a substrate of cytochrome P450 1A2 unrelated to CYP1A2*1C (-2964G>A) and *1F (734C>A) gene polymorphisms.
Xiao J; Huang WH; Peng JB; Tan ZR; Ou-Yang DS; Hu DL; Zhang W; Chen Y
Biomed Res Int; 2014; 2014():405071. PubMed ID: 25025048
[TBL] [Abstract][Full Text] [Related]
2. Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.
Han XM; Ouyang DS; Chen XP; Shu Y; Jiang CH; Tan ZR; Zhou HH
Br J Clin Pharmacol; 2002 Nov; 54(5):540-3. PubMed ID: 12445035
[TBL] [Abstract][Full Text] [Related]
3. Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers.
Wang L; Hu Z; Deng X; Wang Y; Zhang Z; Cheng ZN
Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):257-63. PubMed ID: 23167834
[TBL] [Abstract][Full Text] [Related]
4. Genetic association analysis of functional polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene with tardive dyskinesia in Japanese patients with schizophrenia.
Matsumoto C; Ohmori O; Shinkai T; Hori H; Nakamura J
Psychiatr Genet; 2004 Dec; 14(4):209-13. PubMed ID: 15564895
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers.
Chen Y; Xiao P; Ou-Yang DS; Fan L; Guo D; Wang YN; Han Y; Tu JH; Zhou G; Huang YF; Zhou HH
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):828-33. PubMed ID: 19215233
[TBL] [Abstract][Full Text] [Related]
6. Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory Analysis.
Tian DD; Natesan S; White JR; Paine MF
Clin Transl Sci; 2019 Jan; 12(1):39-46. PubMed ID: 30387917
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.
Sachse C; Bhambra U; Smith G; Lightfoot TJ; Barrett JH; Scollay J; Garner RC; Boobis AR; Wolf CR; Gooderham NJ;
Br J Clin Pharmacol; 2003 Jan; 55(1):68-76. PubMed ID: 12534642
[TBL] [Abstract][Full Text] [Related]
8. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis.
Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki SMA
PLoS One; 2017; 12(9):e0183424. PubMed ID: 28934216
[TBL] [Abstract][Full Text] [Related]
10. Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.
Takata K; Saruwatari J; Nakada N; Nakagawa M; Fukuda K; Tanaka F; Takenaka S; Mihara S; Marubayashi T; Nakagawa K
Eur J Clin Pharmacol; 2006 Jan; 62(1):23-8. PubMed ID: 16385402
[TBL] [Abstract][Full Text] [Related]
11. Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk.
Kim IY; O'Reilly ÉJ; Hughes KC; Gao X; Schwarzschild MA; McCullough ML; Hannan MT; Betensky RA; Ascherio A
Mov Disord; 2018 Mar; 33(3):414-420. PubMed ID: 29318639
[TBL] [Abstract][Full Text] [Related]
12. CYP1A2, GSTM1, and GSTT1 polymorphisms and diet effects on CYP1A2 activity in a crossover feeding trial.
Peterson S; Schwarz Y; Li SS; Li L; King IB; Chen C; Eaton DL; Potter JD; Lampe JW
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3118-25. PubMed ID: 19843669
[TBL] [Abstract][Full Text] [Related]
13. Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.
Sachse C; Brockmöller J; Bauer S; Roots I
Br J Clin Pharmacol; 1999 Apr; 47(4):445-9. PubMed ID: 10233211
[TBL] [Abstract][Full Text] [Related]
14. Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2.
Labedzki A; Buters J; Jabrane W; Fuhr U
Biochem Pharmacol; 2002 Jun; 63(12):2159-67. PubMed ID: 12110375
[TBL] [Abstract][Full Text] [Related]
15. Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A2*1F polymorphism on CYP1A2 phenotyping by melatonin.
Härtter S; Korhonen T; Lundgren S; Rane A; Tolonen A; Turpeinen M; Laine K
Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):300-4. PubMed ID: 17040215
[TBL] [Abstract][Full Text] [Related]
16. Caffeine increases tear volume depending on polymorphisms within the adenosine A2a receptor gene and cytochrome P450 1A2.
Arita R; Yanagi Y; Honda N; Maeda S; Maeda K; Kuchiba A; Yamaguchi T; Yanagihara Y; Suzuki H; Amano S
Ophthalmology; 2012 May; 119(5):972-8. PubMed ID: 22336631
[TBL] [Abstract][Full Text] [Related]
17. Why dried blood spots are an ideal tool for CYP1A2 phenotyping.
De Kesel PM; Lambert WE; Stove CP
Clin Pharmacokinet; 2014 Aug; 53(8):763-71. PubMed ID: 24980692
[TBL] [Abstract][Full Text] [Related]
18. Caffeine, selected metabolic gene variants, and risk for neural tube defects.
Schmidt RJ; Romitti PA; Burns TL; Murray JC; Browne ML; Druschel CM; Olney RS;
Birth Defects Res A Clin Mol Teratol; 2010 Jul; 88(7):560-9. PubMed ID: 20641098
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics.
Saiz-Rodríguez M; Ochoa D; Belmonte C; Román M; Vieira de Lara D; Zubiaur P; Koller D; Mejía G; Abad-Santos F
J Psychopharmacol; 2019 Apr; 33(4):522-531. PubMed ID: 30789308
[TBL] [Abstract][Full Text] [Related]
20. Development of a high throughput single nucleotide polymorphism screening method for the cytochrome P450 1A2 polymorphisms CYP1A2*1C and CYP1A2*1F: are they useful as predictive markers in mental disorders?
Klemm M; Eidens M; Lorenz M; Prause S; Weise A; Dahmen N; Forst T; Pfützner A
Clin Lab; 2010; 56(9-10):473-80. PubMed ID: 21086794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
